CSIMarket


Spectrum Pharmaceuticals Inc   (SPPI)
Other Ticker:  
 


 

Spectrum Pharmaceuticals Inc

SPPI's Financial Statements and Analysis



Spectrum Pharmaceuticals Inc narrowed III. Quarter net loss per share of $-0.12 compare to net loss per share of $-0.21 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.17 realized in previous quarter.


III. Quarter
Earnings Per Share Revenues
$ -0.12 $  0 Mill
$+0.09     Unch.    



Spectrum Pharmaceuticals Inc 's Revenue fell by 0 % in III. Quarter (Sep 30 2022) year on year, to $0 million and declined by sequentially.


Spectrum Pharmaceuticals Inc is Expected to report next financial results on March 16, 2023.

More on SPPI's Income Statement



Spectrum Pharmaceuticals Inc 's in III. Quarter recorded net loss of $-21.925 million, an improvement compare to net loss of $-33.084 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-29.048 million realized in previous quarter.

More on SPPI's Growth

SPPI's Cash flow In III. Quarter company's net cash flow was $31 million


Spectrum Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Spectrum Pharmaceuticals Inc payed $ -0.54 cash per share, on a free-cash flow basis .